infection control and antimicrobial resistance

28
Infection Control and antimicrobial resistance Evelina Tacconelli Infectious Diseases Tuebingen University Germany

Upload: others

Post on 14-Jul-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Infection Control and antimicrobial resistance

Infection Control

and antimicrobial resistance

Evelina Tacconelli

Infectious Diseases

Tuebingen University

Germany

Page 2: Infection Control and antimicrobial resistance

Preventing MDR-Gram positive

Open or closed issues?

• Targeted screening vs universal screening

• PCR vs conventional cultures (screening)

• Room isolation / contact precaution vs no CP

• Target vs universal decolonisation

Page 3: Infection Control and antimicrobial resistance

Preventing MDR-Gram negative

Open or closed issues?

• Best combination of interventions

• CP for patients colonised or infected with ESBL-E. coli • Chlorexidine bath

• Decolonisation

Page 4: Infection Control and antimicrobial resistance

Preventing MDR

Open or closed issues?

• Antimicrobial stewardship programme

• Impact of the increase of elderly population

• Outcome assessment

• PUBLIC-PRIVATE COLLABORATIVE RESEARCH

Page 5: Infection Control and antimicrobial resistance

Quezada, AAC 2012

Page 6: Infection Control and antimicrobial resistance

Schinasi L, (2013)

Page 7: Infection Control and antimicrobial resistance

Fuller, Plos One Sept 2013

Page 8: Infection Control and antimicrobial resistance

Fuller, Plos One Sept 2013

Page 9: Infection Control and antimicrobial resistance

Tacconelli, Lancet Infect Dis, 2009

Type of tests

Molecular vs Cultures

Page 10: Infection Control and antimicrobial resistance

1. Isolation + decolonization

reduces transmission by

64%

2. Undetected MRSA-positive

patients were estimated to

be the source of 75% of total

transmission events.

3. Isolation measures

combined with

decolonization treatment

were strongly associated

with a reduction in MRSA

transmission in hospital

general wards.

Worby, Am J Ep April 2013

Page 11: Infection Control and antimicrobial resistance

Universal decolonisation

Huang, NEJM, June 2013

3 groups

universal screening

+ isolation

universal screening

+ isolation +

decolonisation

universal

decolonisation

(chlorexidine +

mupirocin)

One BSI infection

was prevented per

54 patients who

underwent

decolonisation

Page 12: Infection Control and antimicrobial resistance

Shweizer, BMJ 2013

Page 13: Infection Control and antimicrobial resistance

• 5726 patients included

• BSI due to MRSA

• 1.8 x 1,000 hospital-admission

• BSI due to ESBL+

Enterobacteriaceae

• 3.1 x 1,000 hospital-admission

Tacconelli, ECCMD 2012, 2013

http://www.saturn-project.eu/

Page 14: Infection Control and antimicrobial resistance

Chairperson: Evelina Tacconelli (Tuebingen, Germany)

• Barry Cookson (Health Protection Agency, London, UK)

• Stephanie Dancer (Hairmyres Hospital, East Kilbride,

Lanarkshire, UK)

• Uwe Frank (Heidelberg University Hospital, Heidelberg,

Germany)

• Gunnar Kahlmeter (Central Hospital, Växjö, Sweden)

• Jesus Rodrigues Bano (Hospital Universitario Virgen

Macarena, Sevilla, Spain)

• Nalini Singh / Deborak Yokoe (USA)

Tacconeli, CMI, under publication (free access)

Page 15: Infection Control and antimicrobial resistance

Multifaceted strategy effectiveness for MDR-GN

Tacconelli et al, under revision

HH

Education

CP

Combinations of interventions significantly

associated with effectiveness

HH

Education

CP

Isolation room

OR = 6.1 OR = 8.3

Page 16: Infection Control and antimicrobial resistance

Chlorexidine bathing

Climo NEJM 2013

Page 17: Infection Control and antimicrobial resistance

Tacconelli, AAC, 2009

Risk of MRSA new acquisition after antibiotic therapy in hospitalized patients

Page 18: Infection Control and antimicrobial resistance

Cochrane review (P. Davey 2013)

• The main comparison was between persuasive and

restrictive methods.

• Overall, the 89 studies showed that the methods improved

prescribing.

• 21 studies showed that the methods decreased the number

of infections in hospital.

• The restrictive methods appeared to have a larger effect

than persuasive methods.

Page 19: Infection Control and antimicrobial resistance

ESCMID Guidelines

to control the spread of MDR-GNB 2013

• Epidemic setting: 17 interventions

• Endemic setting: 7 interventions

• Moderate level of evidence / strong recommendations for:

• MDR-A. baumannii (epidemic setting)

• ESBL-producing Enterobacteriaceae (endemic setting)

Page 20: Infection Control and antimicrobial resistance

1. University Hospital

Freiburg, Germany (WP

1-3, 8)

2. Mater Dei Hospital,

Msida, Malta (WP 4)

3. Institute of Public Health,

Brussels, Belgium (WP

5)

4. Università Cattolica,

Rome, Italy (WP 6)

5. Radboud University

Nijmegen Medical

Centre, The Netherlands

(WP 7)

Only 56% of ICU have an ATBS

Page 21: Infection Control and antimicrobial resistance

Definition of effectiveness of ATBS

New parameters

• resistance rate x 1000 HA / DH

• mortality attributable to infection

• overall length of hospitalization

• periods spent in specific care areas such as the ICU’s

• hospitalisation within 1 months

• rates of recurrent infection

• the frequency with which specific laboratory

studies are performed

• antibiotic usage patterns, and institutional

antimicrobial resistance patterns.

Lack of agreement about outocome indicators / heterogeneity of reports

Page 22: Infection Control and antimicrobial resistance

Decolonisation

• 6 CT

• 2 RCT

• 1 KRKP

• No evidence to recommend decolonisation to reduce the

spreading of ESBL-producing bacteria

Page 23: Infection Control and antimicrobial resistance
Page 24: Infection Control and antimicrobial resistance

Major comments

a) International networking and societies should play an

“homogenizing” role

b) Revision and improvement of STROBE items for

epidemiological studies on ARI to improve the quality level of

evidence

c) New studies and agreement on outcome indicators

d) Consensus among clinicians, researchers, epidemiologists,

pharmacologists, pharma companies, governative entities,

control entities on new outcome indicators for clinical

evaluation of new antibiotics

Page 25: Infection Control and antimicrobial resistance

Preventing MDR-Gram positive

Open or closed issues?

• Targeted screening vs universal screening

• PCR vs conventional cultures (screening)

• Room isolation / contact precaution vs no CP

• Target vs universal decolonisation

• Decolonisation

Page 26: Infection Control and antimicrobial resistance

Preventing MDR-Gram negative

Open or closed issues?

• Best combination for best effectiveness

• CP for patients colonised or infected with ESBL-E. coli

• Chlorexidine bath

• Decolonisation

Page 27: Infection Control and antimicrobial resistance

Preventing MDR

Open or closed issues?

• Antimicrobial stewardship programme

• Impact of the increase of elderly population

• Outcome assessment

• PUBLIC-PRIVATE COLLABORATIVE RESEARCH